Rodella, Margie .

HRN: 21-20-77  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/15/2026
02/22/2026
IV
4.5g
Q6h
T/C Hepatitis Encephalopathy
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: